Infection Surveillance Solution Market Research Report by Component (Services and Software), by Deployment (On-Cloud and On-Premise), by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Infection Surveillance Solution Market is expected to grow from USD 549.92 Million in 2020 to USD 1,097.25 Million by the end of 2025.
2. The Global Infection Surveillance Solution Market is expected to grow from EUR 482.18 Million in 2020 to EUR 962.09 Million by the end of 2025.
3. The Global Infection Surveillance Solution Market is expected to grow from GBP 428.66 Million in 2020 to GBP 855.30 Million by the end of 2025.
4. The Global Infection Surveillance Solution Market is expected to grow from JPY 58,691.46 Million in 2020 to JPY 117,105.44 Million by the end of 2025.
5. The Global Infection Surveillance Solution Market is expected to grow from AUD 798.57 Million in 2020 to AUD 1,593.36 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Infection Surveillance Solution to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the Infection Surveillance Solution Market studied across Services and Software. The Services further studied across Consultation & Training, Implementation, and Maintenance & Support.
Based on Deployment, the Infection Surveillance Solution Market studied across On-Cloud and On-Premise.
Based on End-User, the Infection Surveillance Solution Market studied across Hospital and Long-Term Care Facility.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Infection Surveillance Solution Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Infection Surveillance Solution Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Infection Surveillance Solution Market including 3M Company, Advanced Sterilization Products, Atlas Medical Software, Baxter International Inc., Becton, Dickinson, and Company, Cantel Medical Corporation, Cerner Corporation, DEB Group Ltd., Ecolab, Epic Systems Corporation, Getinge AB, Gojo Industries, Inc., Hygreen, Inc., ICNet International Limited, Premier Inc., RL Solutions, STERIS PLC, Truven Health Analytics, VigiLanz Corporation, and Wolters Kluwer N.V..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Infection Surveillance Solution Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Infection Surveillance Solution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infection Surveillance Solution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infection Surveillance Solution Market?
4. What is the competitive strategic window for opportunities in the Global Infection Surveillance Solution Market?
5. What are the technology trends and regulatory frameworks in the Global Infection Surveillance Solution Market?
6. What are the modes and strategic moves considered suitable for entering the Global Infection Surveillance Solution Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Infection Surveillance Solution Market is expected to grow from USD 549.92 Million in 2020 to USD 1,097.25 Million by the end of 2025.
2. The Global Infection Surveillance Solution Market is expected to grow from EUR 482.18 Million in 2020 to EUR 962.09 Million by the end of 2025.
3. The Global Infection Surveillance Solution Market is expected to grow from GBP 428.66 Million in 2020 to GBP 855.30 Million by the end of 2025.
4. The Global Infection Surveillance Solution Market is expected to grow from JPY 58,691.46 Million in 2020 to JPY 117,105.44 Million by the end of 2025.
5. The Global Infection Surveillance Solution Market is expected to grow from AUD 798.57 Million in 2020 to AUD 1,593.36 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Infection Surveillance Solution to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the Infection Surveillance Solution Market studied across Services and Software. The Services further studied across Consultation & Training, Implementation, and Maintenance & Support.
Based on Deployment, the Infection Surveillance Solution Market studied across On-Cloud and On-Premise.
Based on End-User, the Infection Surveillance Solution Market studied across Hospital and Long-Term Care Facility.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Infection Surveillance Solution Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Infection Surveillance Solution Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Infection Surveillance Solution Market including 3M Company, Advanced Sterilization Products, Atlas Medical Software, Baxter International Inc., Becton, Dickinson, and Company, Cantel Medical Corporation, Cerner Corporation, DEB Group Ltd., Ecolab, Epic Systems Corporation, Getinge AB, Gojo Industries, Inc., Hygreen, Inc., ICNet International Limited, Premier Inc., RL Solutions, STERIS PLC, Truven Health Analytics, VigiLanz Corporation, and Wolters Kluwer N.V..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Infection Surveillance Solution Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Infection Surveillance Solution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infection Surveillance Solution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infection Surveillance Solution Market?
4. What is the competitive strategic window for opportunities in the Global Infection Surveillance Solution Market?
5. What are the technology trends and regulatory frameworks in the Global Infection Surveillance Solution Market?
6. What are the modes and strategic moves considered suitable for entering the Global Infection Surveillance Solution Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Deployment Outlook
3.5. End-User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of surgeries and healthcare-associated infections (HAIs)
5.1.1.2. Stringent government policies for preventing hospital associated infections
5.1.1.3. Increasing healthcare expenditure and favourable insurance policies
5.1.2. Restraints
5.1.2.1. Limited availability of skilled healthcare professional
5.1.3. Opportunities
5.1.3.1. Development of fully automated diagnostic surveillance solution systems with the integration of electronic medical records
5.1.3.2. Potential emerging economies of Asian, African, and South American countries
5.1.4. Challenges
5.1.4.1. High cost associated with the deployment of sulutions
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY COMPONENT
6.1. Introduction
6.2. Services
6.2.1. Consultation & Training
6.2.2. Implementation
6.2.3. Maintenance & Support
6.3. Software
7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY DEPLOYMENT
7.1. Introduction
7.2. On-Cloud
7.3. On-Premise
8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY END-USER
8.1. Introduction
8.2. Hospital
8.3. Long-Term Care Facility
9. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. 3M Company
13.2. Advanced Sterilization Products
13.3. Atlas Medical Software
13.4. Baxter International Inc.
13.5. Becton, Dickinson, and Company
13.6. Cantel Medical Corporation
13.7. Cerner Corporation
13.8. DEB Group Ltd.
13.9. Ecolab
13.10. Epic Systems Corporation
13.11. Getinge AB
13.12. Gojo Industries, Inc.
13.13. Hygreen, Inc.
13.14. ICNet International Limited
13.15. Premier Inc.
13.16. RL Solutions
13.17. STERIS PLC
13.18. Truven Health Analytics
13.19. VigiLanz Corporation
13.20. Wolters Kluwer N.V.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Deployment Outlook
3.5. End-User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of surgeries and healthcare-associated infections (HAIs)
5.1.1.2. Stringent government policies for preventing hospital associated infections
5.1.1.3. Increasing healthcare expenditure and favourable insurance policies
5.1.2. Restraints
5.1.2.1. Limited availability of skilled healthcare professional
5.1.3. Opportunities
5.1.3.1. Development of fully automated diagnostic surveillance solution systems with the integration of electronic medical records
5.1.3.2. Potential emerging economies of Asian, African, and South American countries
5.1.4. Challenges
5.1.4.1. High cost associated with the deployment of sulutions
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY COMPONENT
6.1. Introduction
6.2. Services
6.2.1. Consultation & Training
6.2.2. Implementation
6.2.3. Maintenance & Support
6.3. Software
7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY DEPLOYMENT
7.1. Introduction
7.2. On-Cloud
7.3. On-Premise
8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY END-USER
8.1. Introduction
8.2. Hospital
8.3. Long-Term Care Facility
9. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. 3M Company
13.2. Advanced Sterilization Products
13.3. Atlas Medical Software
13.4. Baxter International Inc.
13.5. Becton, Dickinson, and Company
13.6. Cantel Medical Corporation
13.7. Cerner Corporation
13.8. DEB Group Ltd.
13.9. Ecolab
13.10. Epic Systems Corporation
13.11. Getinge AB
13.12. Gojo Industries, Inc.
13.13. Hygreen, Inc.
13.14. ICNet International Limited
13.15. Premier Inc.
13.16. RL Solutions
13.17. STERIS PLC
13.18. Truven Health Analytics
13.19. VigiLanz Corporation
13.20. Wolters Kluwer N.V.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CONSULTATION & TRAINING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: SCORES
TABLE 104. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 105. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 106. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RANKING
TABLE 107. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 108. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 109. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 110. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 111. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 112. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CONSULTATION & TRAINING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: SCORES
TABLE 104. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 105. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 106. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RANKING
TABLE 107. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 108. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 109. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 110. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 111. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 112. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2025
FIGURE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CONSULTATION & TRAINING, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY MAINTENANCE & SUPPORT, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 VS 2025 (%)
FIGURE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2025
FIGURE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 28. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2025
FIGURE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY TYPE
FIGURE 1. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2025
FIGURE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CONSULTATION & TRAINING, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY MAINTENANCE & SUPPORT, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 VS 2025 (%)
FIGURE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2025
FIGURE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 28. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2025
FIGURE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, BY TYPE
